pharmaceuticals

Upadacitinib shows promise for papulopustular rosacea in pilot study

‘Major step forward’: TGA approves first pharmacological therapy for OSA

New consensus for JAKi use in AD

Oral JAKi improves phototherapy-induced repigmentation in vitiligo

New authority requirement adding to the PBS ‘clickfest’

Dupilumab for chronic spontaneous urticaria gets tick

Bimekizumab now TGA approved for hidradenitis suppurativa

Eli Lilly exec says slow PBS threatens clinical trials funding
